• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy.

作者信息

Cairns J A, Connolly S J

机构信息

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

出版信息

Circulation. 1991 Aug;84(2):469-81. doi: 10.1161/01.cir.84.2.469.

DOI:10.1161/01.cir.84.2.469
PMID:1860192
Abstract
摘要

相似文献

1
Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy.非风湿性心房颤动。中风风险及抗血栓治疗的作用。
Circulation. 1991 Aug;84(2):469-81. doi: 10.1161/01.cir.84.2.469.
2
Antithrombotic therapy in atrial fibrillation.心房颤动的抗栓治疗
Chest. 1998 Nov;114(5 Suppl):579S-589S. doi: 10.1378/chest.114.5_supplement.579s.
3
Antithrombotic therapy in stroke prevention.中风预防中的抗血栓治疗。
Br J Hosp Med. 1994;52(5):239.
4
Role of antithrombotic therapy in atrial fibrillation.抗血栓治疗在心房颤动中的作用。
Indian Heart J. 1993 Nov-Dec;45(6):451-7.
5
Antithrombotic therapy in stroke prevention.预防中风的抗栓治疗。
Br J Hosp Med. 1994;52(5):239.
6
[Nonrheumatic atrial fibrillation. Rhythm conversion or anticoagulation?].[非风湿性心房颤动。节律转复还是抗凝治疗？]
Dtsch Med Wochenschr. 1992 Mar 27;117(13):505-10. doi: 10.1055/s-2008-1062341.
7
Anticoagulation in nonvalvular atrial fibrillation.
J La State Med Soc. 1996 Nov;148(11):479-84.
8
Antithrombotic therapy in atrial fibrillation.心房颤动的抗栓治疗
Can Fam Physician. 1996 Jul;42:1341-5.
9
Atrial fibrillation and anticoagulation.
Adv Intern Med. 1999;44:239-65.
10
Warfarin vs aspirin and AFASAK 2.华法林与阿司匹林及AFASAK 2研究对比
Arch Intern Med. 1999 May 10;159(9):1010-1. doi: 10.1001/archinte.159.9.1010.

引用本文的文献

1
Comparative Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients with Chronic Liver Disease: A Systematic Review and Meta-analysis.直接口服抗凝剂与华法林在慢性肝病房颤患者中的疗效和安全性比较：一项系统评价和荟萃分析。
J Innov Card Rhythm Manag. 2024 Oct 15;15(10):6052-6061. doi: 10.19102/icrm.2024.15103. eCollection 2024 Oct.
2
Sex-differences in post-discharge outcomes among patients hospitalized for atrial fibrillation.因心房颤动住院患者出院后结局的性别差异。
Clin Cardiol. 2019 Jan;42(1):84-92. doi: 10.1002/clc.23111. Epub 2018 Dec 19.
3
Accurate Detection Of Left Atrial Thrombus Prior To Atrial Fibrillation Ablation In Patients With Therapeutic Anticoagulation: Does Transesophageal Echocardiography Beat Conventional Wisdom?
接受治疗性抗凝治疗的患者在房颤消融术前左心房血栓的准确检测：经食管超声心动图是否优于传统方法？
J Atr Fibrillation. 2009 Feb 1;1(5):169. doi: 10.4022/jafib.169. eCollection 2009 Feb-Mar.
4
Patients' and physicians' perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review.患者与医生对口服抗凝治疗及心房颤动的认知与态度：一项定性系统评价
BMC Fam Pract. 2017 Jan 13;18(1):3. doi: 10.1186/s12875-016-0574-0.
5
Biomarkers in electrophysiology: role in arrhythmias and resynchronization therapy.电生理学中的生物标志物：在心律失常和再同步治疗中的作用。
J Interv Card Electrophysiol. 2015 Jun;43(1):31-44. doi: 10.1007/s10840-015-9982-7. Epub 2015 Feb 27.
6
Apixaban, dabigatran, and rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis.阿哌沙班、达比加群和利伐沙班与华法林预防非瓣膜性心房颤动卒中共效性分析：成本效益研究。
Clin Drug Investig. 2014 Jan;34(1):9-17. doi: 10.1007/s40261-013-0144-3.
7
CHADS(2) score is predictive of left atrial thrombus on precardioversion transesophageal echocardiography in atrial fibrillation.CHADS(2)评分可预测房颤患者复律前经食管超声心动图检查发现的左心房血栓。
Am J Cardiovasc Dis. 2011;1(2):159-65. Epub 2011 Jul 28.
8
Coronary artery disease, left ventricular hypertrophy and diastolic dysfunction are associated with stroke in patients affected by persistent non-valvular atrial fibrillation: a case-control study.冠心病、左心室肥厚和舒张功能障碍与持续性非瓣膜性心房颤动患者的中风有关：一项病例对照研究。
Heart Int. 2009 Jun 30;4(1):e2. doi: 10.4081/hi.2009.e2.
9
Effect of spironolactone on patients with atrial fibrillation and structural heart disease.螺内酯对合并结构性心脏病的心房颤动患者的影响。
Clin Cardiol. 2011 Jul;34(7):415-9. doi: 10.1002/clc.20914. Epub 2011 Jun 14.
10
Targets and endpoints in ablation therapy for atrial fibrillation in the light of pathophysiological mechanisms.基于病理生理机制的心房颤动消融治疗的靶点与终点
J Interv Card Electrophysiol. 2006 Jan;15(1):27-33. doi: 10.1007/s10840-006-6334-7.